Search results
Guardant Health Stock Jumps. Blood Test for Cancer Moves Toward FDA Approval.
Barrons.com· 1 day agoShares of Guardant Health were rising sharply after the cancer company said a Food and Drug...
FDA approves first DLL3 × CD3 bispecific T-cell engager for lung cancer
Nature· 2 days agoDiscover the world’s best science and medicine | Nature.com
Mirat Shah, MD, on Elacestrant's FDA Approval for Breast Cancer With ESR1 Mutations
MedPage Today· 5 days agoFDA scientists published a detailed rationale for the approval of elacestrant (Orserdu), the first...
Why is the FDA looking to ban this ingredient found in most sodas? - Dexerto
Dexerto· 2 days agoA common ingredient used in sodas like Mountain Dew and Gatorade in the past has been flagged by the...
Guardant Health Stock Jumps 12%
Barrons.com· 1 day agoThe FDA is expected to decide whether or not to approve the blood test, Shield, later this year.Read the full article
U.S. FDA advisers back approval for Guardant's blood-based cancer test (May 23) By Reuters
Investing.com· 2 days agoThe panel voted seven-to-two in favor of benefits outweighing risks when using the test called...
FDA approves 2 Eylea biosimilars
Becker’s Hospital Review· 6 days agoThe FDA granted approval to Biocon Biologics' drug Yesafili and Samsung Bioepis and Biogen's drug Opuviz, the agency announced May 20. The two drugs are biosimilars for Eylea ...
US FDA staff says Guardant's test may fail to detect some pre-cancerous tumors
Reuters via Yahoo News· 5 days agoThe reviewers, however, said the test may increase compliance with screening for colorectal cancer...
U.S. FDA advisers back approval for Guardant's blood-based cancer test (May 23)
Reuters via AOL· 2 days agoAdvisers to the U.S. Food and Drug Administration on Thursday recommended for the approval of...
FDA Withdraws Approval of FGFR Inhibitor for Bile Duct Cancer
MedPage Today· 6 days agoThe FDA has withdrawn the approval of infigratinib (Truseltiq) as a second-line treatment for...
